The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
Open accessAbstract
Background: Genetic testing for hereditary cancer syndromes contributes to the medical management of patients who may be at increased risk of one or more cancers. BRCA1 and BRCA2 testing for hereditary breast and ovarian cancer is one such widely used test. However, clinical testing methods with high sensitivity for deleterious mutations in these genes also detect many unclassified variants, primarily missense substitutions. Methods: We developed an extension of the Grantham difference, called A-GVGD, to score missense substitutions against the range of variation present at their position in a multiple sequence alignment. Combining two methods, co-occurrence of unclassified variants with clearly deleterious mutations and A-GVGD, we analysed most of the missense substitutions observed in BRCA1. Results: A-GVGD was able to resolve known neutral and deleterious missense substitutions into distinct sets. Additionally, eight previously unclassified BRCA1 missense substitutions observed in trans with one or more deleterious mutations, and within the cross-species range of variation observed at their position in the protein, are now classified as neutral. Discussion: The methods combined here can classify as neutral about 50% of missense substitutions that have been observed with two or more clearly deleterious mutations. Furthermore, odds ratios estimated for sets of substitutions grouped by A-GVGD scores are consistent with the hypothesis that most unclassified substitutions that are within the cross-species range of variation at their position in BRCA1 are also neutral. For most of these, clinical reclassification will require integrated application of other methods such as pooled family histories, segregation analysis, or validated functional assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Self-citationAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Amino Acid Difference Formula to Help Explain Protein Evolution
Grantham, R. (1974) · Science · doi:10.1126/science.185.4154.862 · Cited by 2,363
Human non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Self-citationThe Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 667
Cited by
Shihab, H. A., Gough, J., Cooper, D. N., Stenson, P. D., Barker, G. L. A., Edwards, K. J., Day, I. N. M., & Gaunt, T. R. (2013) · Human Mutation · doi:10.1002/humu.22225 · Cited by 1,341
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
Accurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Couch, F. J., Hart, S. N., Sharma, P., Toland, A. E., Wang, X., Miron, P., Olson, J. E., Godwin, A. K., Pankratz, V. S., Olswold, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1414 · Cited by 672
Easton, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
Self-citationComprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease
Rossetti, S., Consugar, M. B., Chapman, A. B., Torres, V. E., Guay-Woodford, L. M., Grantham, J. J., Bennett, W. M., Meyers, C. M., Walker, D. L., Bae, K., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121387 · Cited by 439
College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests
Aziz, N., Zhao, Q., Bry, L., Driscoll, D. K., Funke, B., Gibson, J. S., Grody, W. W., Hegde, M. R., Hoeltge, G. A., Leonard, D. G. B., et al. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0250-cp · Cited by 387
Clinical exome sequencing: results from 2819 samples reflecting 1000 families
Trujillano, D., Bertoli-Avella, A. M., Kumar Kandaswamy, K., Weiss, M. E., Köster, J., Marais, A., Paknia, O., Schröder, R., Garcia-Aznar, J. M., Werber, M., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.146 · Cited by 358
The CREAM Consortium, Tedja, M. S., 23andMe Research Team, UK Biobank Eye and Vision Consortium, Wojciechowski, R., Hysi, P. G., Eriksson, N., Furlotte, N. A., Verhoeven, V. J. M., Iglesias, A. I., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0127-7 · Cited by 355
Mathe, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj518 · Cited by 340
Neveling, K., Feenstra, I., Gilissen, C., Hoefsloot, L. H., Kamsteeg, E.-J., Mensenkamp, A. R., Rodenburg, R. J. T., Yntema, H. G., Spruijt, L., Vermeer, S., et al. (2013) · Human Mutation · doi:10.1002/humu.22450 · Cited by 331
Mensenkamp, A. R., Vogelaar, I. P., van Zelst–Stams, W. A. G., Goossens, M., Ouchene, H., Hendriks–Cornelissen, S. J. B., Kwint, M. P., Hoogerbrugge, N., Nagtegaal, I. D., & Ligtenberg, M. J. L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.002 · Cited by 328
Massively Parallel Functional Analysis of BRCA1 RING Domain Variants
Starita, L. M., Young, D. L., Islam, M., Kitzman, J. O., Gullingsrud, J., Hause, R. J., Fowler, D. M., Parvin, J. D., Shendure, J., & Fields, S. (2015) · Genetics · doi:10.1534/genetics.115.175802 · Cited by 297
Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
Ghosh, R., Oak, N., & Plon, S. E. (2017) · Genome biology · doi:10.1186/s13059-017-1353-5 · Cited by 233
Whole exome sequencing of suspected mitochondrial patients in clinical practice
Wortmann, S. B., Koolen, D. A., Smeitink, J. A., den van Heuvel, L., & Rodenburg, R. J. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9823-y · Cited by 233
Hicks, S., Wheeler, D. A., Plon, S. E., & Kimmel, M. (2011) · Human Mutation · doi:10.1002/humu.21490 · Cited by 223
In silico analysis of missense substitutions using sequence-alignment based methods
Tavtigian, S. V., Greenblatt, M. S., Lesueur, F., Byrnes, G. B., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20892 · Cited by 199
Self-citationA High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants
Bouwman, P., van der Gulden, H., van der Heijden, I., Drost, R., Klijn, C. N., Prasetyanti, P., Pieterse, M., Wientjens, E., Seibler, J., Hogervorst, F. B. L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0094 · Cited by 140
Towards precision medicine: advances in computational approaches for the analysis of human variants
Peterson, T. A., Doughty, E., & Kann, M. G. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.08.008 · Cited by 123
Thompson, B. A., Greenblatt, M. S., Vallee, M. P., Herkert, J. C., Tessereau, C., Young, E. L., Adzhubey, I. A., Li, B., Bell, R., Feng, B., et al. (2013) · Human Mutation · doi:10.1002/humu.22214 · Cited by 95
Self-citationVIPdb, a genetic variant impact predictor database
Hu, Z., Yu, C., Furutsuki, M., Andreoletti, G., Ly, M., Hoskins, R., Adhikari, A. N., & Brenner, S. E. (2019) · Human Mutation · doi:10.1002/humu.23858 · Cited by 37
Ritelli, M., Cinquina, V., Venturini, M., Pezzaioli, L., Formenti, A. M., Chiarelli, N., & Colombi, M. (2019) · Genes · doi:10.3390/genes10020135 · Cited by 33
“To evaluate the putative pathogenicity of the AEBP1 missense variant, which was submitted to the LOVD Ehlers–Danlos Syndrome Variant Database [19], we used the following mutation prediction programs: Mutation Assessor [20], PhD-SNP [21], Align GVD [22], SIFT [23], Mutation Taster [24], PolyPhen2 [25], PROVEAN [26], Mu…”
MethodCraiu, D., Dragostin, O., Dica, A., Hoffman-Zacharska, D., Gos, M., Bastian, A. E., Gherghiceanu, M., Rolfs, A., Nahavandi, N., Craiu, M., et al. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.07.008 · Cited by 31
Bowles, B., Ferrer, A., Nishimura, C. J., Pinto e Vairo, F., Rey, T., Leheup, B., Sullivan, J., Schoch, K., Stong, N., Agolini, E., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62347 · Cited by 20
Cankara, F., & Doğan, T. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.09.017 · Cited by 1
Metadata
- Authors
- Tavtigian, S. V., Deffenbaugh, A. M., Yin, L., Judkins, T., Scholl, T., Samollow, P. B., de Silva, D., Zharkikh, A., & Thomas, A.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2005-07-13
- Volume
- 43
- Issue
- 4
- Pages
- 295-305
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2132752562
- Cited by
- 669
- References
- 30
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.